AU Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals Ltd

Watchlist
  • 15.240
  • +0.440+2.97%
20min DelayMarket Closed May 3 16:00 AET
5.04BMarket Cap952.50P/E (Static)

Telix Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telix Pharmaceuticals Ltd Earnings Date

Currency: AUD

Period

FY2023 Annual Report

Feb 22, 2024

Revenue(YoY)

496.66M

+218.40%
EPS(YoY)

0.02

+104.81%
Analyst Rating

Strong Buy

Apr 30, 2024

Telix Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 178.000M--
--2024/Q2-- / 178.000M--
Aug 23, 20232023/Q2120.700M / 120.000M--
Feb 27, 20232022/Q480.749M / 68.850M--
Oct 20, 20222022/Q355.300M / ----
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 178.000M--
--2024/Q2-- / 178.000M--
Aug 23, 20232023/Q2120.700M / 120.000M--
Feb 27, 20232022/Q480.749M / 68.850M--
Oct 20, 20222022/Q355.300M / ----

Telix Pharmaceuticals Ltd Earnings Reports

  • Telix Pharmaceuticals Ltd: 2023 Full Year Results Presentation

    Feb 22 02:35 ET

  • Telix Pharmaceuticals Ltd: 2023 Full Year Results Release

    Feb 22 02:35 ET

  • Telix Pharmaceuticals Ltd: Appendix 4E and 2023 Annual Report

    Feb 22 02:34 ET

  • Telix Pharmaceuticals Ltd: 1H 2023 Results Presentation

    Aug 23, 2023 04:45 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Strong Buy

    • Strong Buy

      71.43%

    • Buy

      14.29%

    • Hold

      14.29%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    %Chg